Virginio Cepas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Virginio Cepas has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Ratia
ISGlobal, Hospital Clínic—Universitat de Barcelona, Barcelona, Spain
1 shared publication - Sara Maria Soto
ISGlobal
1 shared publication - Victoria Ballén
Affiliation ISGlobal, Barcelona, Spain
1 shared publication - Yaiza Gabasa
Barcelona Institute for Global Health (ISGlobal), 08028 Barcelona, Spain
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 26 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1103
Clinical Escherichia coli: From Biofilm Formation to New Antibiofilm Strategies
Escherichia coli is one of the species most frequently involved in biofilm-related diseases, being especially important in urinary tract infections, causing relapses or chronic infections. Compared to their planktonic analogues, biofilms confer to the bacteria the capacity to be up to 1000-fold more resistant to antibiotics and to evade the action of the host’s immune system. For this reason, biofilm-related infections are very difficult to treat. To develop new strategies against biofilms, it is important to know the mechanisms involved in their formation. In this review, the different steps of biofilm formation in E. coli, the mechanisms of tolerance to antimicrobials and new compounds and strategies to combat biofilms are discussed.
- 26 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1103
Top Cited PapersOpen AccessClinical Escherichia coli: From Biofilm Formation to New Antibiofilm Strategies
Escherichia coli is one of the species most frequently involved in biofilm-related diseases, being especially important in urinary tract infections, causing relapses or chronic infections. Compared to their planktonic analogues, biofilms confer to the bacteria the capacity to be up to 1000-fold more resistant to antibiotics and to evade the action of the host’s immune system. For this reason, biofilm-related infections are very difficult to treat. To develop new strategies against biofilms, it is important to know the mechanisms involved in their formation. In this review, the different steps of biofilm formation in E. coli, the mechanisms of tolerance to antimicrobials and new compounds and strategies to combat biofilms are discussed.